Antonio Rapacciuolo
Antonio Rapacciuolo is an expert in Cardiology at Federico II University Hospital (Italy). Antonio Rapacciuolo has authored 233 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 8 of them ongoing. SLR score: 835 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Geriatrics - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 233
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Same-Day Discharge After Cardiac Device Generator Replacement: Safety and Patient Acceptability. PMID 42816768 — safety, hematoma, arrhythmias, cardiac, infections | Pacing Clin Electrophysiol | 2026 | 0 |
| Impairment of the adaptive SK1/S1P cardioprotective axis in chronic heart failure. PMID 42603626 — cells, adrenergic agents, serum, heart failure, heart, aging, stress, physiological, sphingosine, biomarkers, sphingosine kinase | Exp Gerontol | 2026 | 0 |
| Minimalist LAAO in contemporary practice: is conscious sedation ready for prime time? PMID 42765776 — conscious sedation, cardiovascular diseases | J Cardiovasc Med (Hagerstown) | 2026 | 1 |
| Cardiac implantable electronic device infection awareness and management: nationwide survey amongst general practitioners. PMID 42710013 — general practitioners, electrophysiology, cardiovascular diseases, signs and symptoms, therapeutics, education, prognosis, infections | J Cardiovasc Med (Hagerstown) | 2026 | 0 |
| Time-Dependent Diagnostic Yield and Therapeutic Impact of Implantable Loop Recorders, Brugada Syndrome as the Exception. PMID 42702066 — tachycardia, ventricular, syncope, electrophysiology, stroke, atrial fibrillation, tachycardia, diagnosis, therapeutics, brugada syndrome | J Cardiovasc Electrophysiol | 2026 | 0 |
Clinical Studies 19
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
8 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Comparison between single and dual therapy with drugs that inhibits platelet aggregation in patient undergoing the percutaneous left atrial appenDAge closure (ARMYDA AMULET in which people will be allocated by chance to receive two different options of treatment and which will involves different clinical sites) 2024-515361-34-00 — atrial appendage, pharmaceutical preparations, atrial fibrillation, platelet aggregation, therapeutics, blood platelets, head | Phase 4 | Recruiting | 2021 |
| Multicenter Evaluation of Patients Using LATITUDE Monitoring System NCT06311149 — registries, death, sudden, monitoring, ambulatory, heart failure, heart, arrhythmias, cardiac, cardiovascular diseases, cardiac resynchronization therapy, death, sudden, cardiac, therapeutics, defibrillators, implantable, defibrillators | N/A | Recruiting | 2023 |
| Association Between Cardiac ARRHYTHMIAs and Glycemic Variability in Patient With Type 2 Diabetes Monitored Through FREEstyle Libre and Bluetooth Technology NCT05994755 — diabetes mellitus, heart failure, heart, arrhythmias, cardiac, atrial fibrillation, diabetes mellitus, type 2 | N/A | Not yet recruiting | 2023 |
| Post market Prospective Multicenter Randomized and Single blinded Clinical Investigation to Evaluate Whether Cardiac Re Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV) NCT06044597 — immunodeficiency virus, bovine, heart failure, heart, therapeutics | N/A | Not yet recruiting | 2023 |
| Head to head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure a Multicenter Randomized Study NCT05554822 — atrial appendage, clopidogrel, aspirin, atrial fibrillation, therapeutics | Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map